38
Participants
Start Date
December 1, 2024
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Dapagliflozin (DAPA)
"Participants will receive 10mg/day of dapagliflozin orally. The administration will occur within a synchronous range, meaning that the time difference between dapagliflozin administration and glucocorticoid administration should not exceed 12 hours."
Unidad Medica de Alta Especialidad Hospital de Especialidades No. 1 CMN Bajio, León
Instituto Mexicano del Seguro Social
OTHER_GOV
Lauro Fabián Amador Medina
OTHER_GOV